U.S. Markets close in 5 hrs 32 mins

Ionis Pharmaceuticals, Inc (ISIS)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
57.560.00 (0.00%)
As of 5:00PM EDT. Market open.
Full screen
Previous Close0.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Ionis Pharma Lipid Disorder Candidate Positive in Phase III
    Zacks5 months ago

    Ionis Pharma Lipid Disorder Candidate Positive in Phase III

    Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, Inc. (IONS), recently announced positive results from a pivotal phase III study evaluating its pipeline candidate volanesorsen for treatment of patients with familial chylomicronemia syndrome.

  • Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive
    Investor's Business Daily6 months ago

    Kite, Ionis Outplay Med Sector As Perrigo, Tenet, Valeant Dive

    Kite outperformed med stocks Tuesday, gapping up on lymphoma trial results even as Perrigo and Tenet stocks fell by double digits.

  • Ionis Pharmaceuticals (IONS) Beats on Q4 Earnings
    Zacks6 months ago

    Ionis Pharmaceuticals (IONS) Beats on Q4 Earnings

    Ionis reported earnings of 21 cents including stock based compensation. However, excluding stock based compensation the company reported earnings of 33 cents that surpassed the Zacks Consensus Estimate of loss of 20 cents.